|Basis of Allotment|
is only an advertisement for Information purposes and not a Prospectus announcement.)
AJOONI BIOTECH LIMITED
Our Company was. originally incorporated at Chandigarh as "Ajooni Biotech Private Limiled" on 17th February, 2010 under the provisions of the Companies Act 1956 vide Certificate of Incorporation issued by the Registrar of Companies, Punjab, Himachal Pradesh and Chandigarh. Consequent upon the conversion of our Company to public limited company, the name of our Company was changed to "Ajooni Biotech Limited" and fresh certificate of incorporation dated 27th September. 2017 was issued by the Registrar of Companies, Punjab & Chandigarh at Chandigarh. For furlher details of incorporation, change of name and registered oflice of our Company, please refer to chapter titled "General Information" and "Our History and Certain Other Corporate Matters" begning on pages 52 and page 129 respectively of the Prospectus.
Registered Office: D-118, Industrial Area. Phase-7,
Mohali, Punjab - 160055, India. | Tel: +91 - 0172 - 5020758 - 69
PROMOTERS OF OUR COMPANY: MR. JASJOT SINGH AND M/S HEALTHY BIOSCIENCES PRIVATE LIMITED
BASIS OF ALLOTMENT
PUBLIC ISSUE OF 21,96,000 EQUITY SHARES OF FACE VALUE OF RS 10 EACH ("EQUITY SHARES") OF AJOONI BIOTECH LIMITED (THE "COMPANY" OR THE "ISSUER") FOR CASH AT A PRICE OF RS 30 PER EQUITY SHARE. INCLUDING A SHARE PREMIUM OF RS 20 PER EQUITY SHARE (THE "ISSUE PRICE"), AGGREGATING RS 658.80 LACS ("THE ISSUE"), OF WHICH 1,12,000 EQUITY SHARES OF FACE VALUE OF RS 10 EACH FOR CASH AT A PRICE OF RS. 30 PER EQUITY SHARE. AGGREGATING RS 33.60 LACS WILL BE RESERVED FOR SUBSCRIPTIONS BY THE MARKET MAKER TO THE ISSUE (THE "MARKET MAKER RESERVATION PORTION"). THE ISSUE LESS MARKET MAKER RESERVATION PORTION I.E. ISSUE OF 20,84,000 EQUITY SHARES OF FACE VALUE OF RS 10 EACH CASH AT A PRICE OF RS 30 PER EQUITY SHARE AGGREGATING RS 625.20 LACS IS HEREINAFTER REFERRED TO AS THE "NET ISSUE" THE ISSUE AND THE NET ISSUE WILL CONSTITUTE 37.51% AND 35.59% RESPECTIVELY OF THE POST ISSUE PAID UP EQUITY SHARE CAPITAL OF THE COMPANY.
In terms of Prospectus dated 6th December 2017 and as per Regulation 43(4) of SEBI (ICDR) Regulations, 2009 wherein a minimum of 50 % of the Net issue to Public shall be made available to shall be initially made available to Retail Individual investors as the case may be. The balance net offer of shares to the public shall be made available for allotment to a) individual applicants other than retail investors and b) other investors including corporate bodies/institutions irrespective of no. of shares applied for. The unsubscribed portion of the net offer to any one of the categories specified in (a) or (b) shall/may be made available for allocation in any other category, if so required.
Explanation: for the purpose of Regulation 43 (4) of SEBI (ICDR) Regulations, 2009, if the retail Individual investor is entitled to more than fifty percent, on proportionate basis, the retail individual investors shall be allocated that higher percentage.
THE FACE VALUE OF THE EQUITY SHARES IS RS 10 EACH AND THE ISSUE
PRICE IS RS 30 EACH.
The Equity Shares offered through the Prospectus are proposed to be listed on the
EMERGE platform of National Stock Exchange of India Limited ("NSE") in terms of
the chapter XB of the SEBl (ICDR) Regulations, 2009 as amended from time to time, Company
has received in-Principle approval letter dated 21st November, 2017 frorn NSE for using
its name in the offer document for listing of our Shares on the EMERGE platform of NSE.
The designated stock exchange is National Stock Exchange of India Limited
The issue has received 12,800 applications for 13,36,00,000 Equity Shares (Including Market Maker Application of 1,12,000 Equity Shares} resulting 60,838 times subscription. Out of the same, 231 applications of aggregating 72,92,000 Equity Shares, were not banked. Hence 12,569 applications for 12,63,08.000 Equity Shares (Including Market Maker Application of 1,12,000 Equity Shares) resulting 57.517 times subscription was considered. The details of the applications received in the Issue (before Technical rejections.) are as follows:
Detail of the Applications Received (Before Technical Rejection and Multiple Applications):
The details of applications rejected by the Registrar on technical grounds (Including multiple applications) are detailed below:
Details of the Valid Applications Received (After Technical Rejection & withdrawal):
Allocation: The Basis of Allotment was finalized in consultation with the Designated Stock Exchange - National Stock Exchange of India limited ("NSE") on 28th December, 2017.
A) Allocation to Market Maker (After Technical Rejections & Withdrawal): The Basis of Allotmend to the Market Maker, at the issue price of Rs 30 per Equity Share, was finalised in consultation with NSE The category was subscribed by 1.000 time. The total number of shares allotted in this category is 1,12,000 Equity shares in full out of reserved portion of 1,12,000 Equity Shares.
B) Allocation to Retail Individual investors (After Technical Rejections & Withdrawal): The Basis of Allotment to the Retail Individual Investors, at the issue price of Rs 30 per Equity Share, was finalized in conultation with NSE. The category was subscribed by 46.736 times. Total number of Shares allotted in this category is 10,44,000 Equity Shares. The category wise basis of allotment is as under:
C) Allocation to Non-Retail investors (After Technical Rejections & Withdrawal): The Basis of Allotment to the Non Retail Investors, at the issue price of Rs 30 per Equity Share, was finalized in consultation with NSE. The category was subscribed by 73.842 times. Total number of Shares allotted in this category is 10,44,000 Equity Shares. The category wise basis of allotment is as under:
The Board of Directors of the Company at its meeting held on 28th December. 2017 has taken or record the Basis of Allocation of Equity Shares approved by the Designated Stock Exchange viz. NSE and has authorized the corporate action for the transter of the Equity Shares/dispatch of share certificates to various successful applicants.
The allotment advice cum refund intimations will be dispatched to the address of the Applicants as registered with the depositories, Further the instructions to self Certified Syndicate Banks being processed on or before 30th December, 2017. In case the same is not received within 10 days, investors may contact at the address given below. The Equity Shares allocated to successful applicants are being credited to their beneficiary accounts subject to validation of the account details with the depositories concerned. The Company is taking steps to get the Equity Shares admitted for trading on the EMERGE Platform of NSE within Six working days from the date of the closure of the Issue. The trading is proposed to be commenced on or before 2nd January, 2018 subject to receipt of listing and trading approvals from National Stock Exchange of India Limned.
INVESTORS PLEASE NOTE
The details of the allotment made would also be hosted on the website of the Registrar to the Issue. Cameo Corporate Services Ltd at All future correspondence in this regard may kindly be addressed to the Registrar to the Issue quoting full name of the First/ Sole applicants, serial number of the Application Form, number of shares applied for and ASBA Bank. details at the address of the Registrar given below:
CAMEO CORPORATE SERVICES LTD
THE LEVEL OF SUBSCRIPTION SHOULD NOT BE TAKEN TO BE INDICATIVE OF EITHER THE MARKET PRICE OF THE EQUITY SHARES ON LISTING OR THE BUSINESS PROSPECTS OF AJOONI BIOTECH LIMITED.
Note: All capitalized terms used and not defined herein shall have the respective meanings assigned to them in the Prospectus.